Clinical Trial Update: Depigoid Birch 5000 Longterm Study in Adults and Adolescents [Phase 3]

View source ↗

Summary

Phase 3 long-term study update for Depigoid Birch 5000 in adults and adolescents with birch pollen allergy and related rhinitis/sensitoconjunctivitis, completed…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Allergic Rhinitis
• Intermittent Asthma
• Rhinoconjunctivitis

Drugs mentioned

• Depigoid Birch 5000 (Birch pollen allergoid)

Snippet

Sponsor: Leti Pharma GmbH | Conditions: Allergic Rhinitis/Rhinoconjunctivitis +-Intermittent Asthma, Sensitization Against Betula Alba (Birch) Pollen | Phase 3 | Status: COMPLETED